Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Operating Leases: 2023-2024

Historic Operating Leases for Compass Therapeutics (CMPX) over the last 2 years, with Dec 2024 value amounting to $6.3 million.

  • Compass Therapeutics' Operating Leases rose 43.48% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 43.48%. This contributed to the annual value of $6.3 million for FY2024, which is 1074.63% up from last year.
  • According to the latest figures from FY2024, Compass Therapeutics' Operating Leases is $6.3 million, which was up 1,074.63% from $536,000 recorded in FY2023.
  • Over the past 5 years, Compass Therapeutics' Operating Leases peaked at $6.3 million during FY2024, and registered a low of $536,000 during FY2023.
  • For the 2-year period, Compass Therapeutics' Operating Leases averaged around $3.4 million, with its median value being $3.4 million (2023).
  • Data for Compass Therapeutics' Operating Leases shows a peak YoY skyrocketed of 1,074.63% (in 2024) over the last 5 years.
  • Over the past 2 years, Compass Therapeutics' Operating Leases (Yearly) stood at $536,000 in 2023, then skyrocketed by 1,074.63% to $6.3 million in 2024.